Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.

ABSTRACT:

Objectives

Epithelial ovarian cancer (EOC) is an aggressive disease in which first line therapy consists of a surgical staging/debulking procedure and platinum based chemotherapy. There is significant interest in clinically applicable, easy to use prognostic tools to estimate risk of recurrence and overall survival. In this study we used a large prospectively collected cohort of women with EOC to validate currently published models and assess prognostic variables.

Methods

Women with invasive ovarian, peritoneal, or fallopian tube cancer diagnosed between 2000 and 2011 and prospectively enrolled into the Mayo Clinic Ovarian Cancer registry were identified. Demographics and known prognostic markers as well as epidemiologic exposure variables were abstracted from the medical re

SUBMITTER: Wahner Hendrickson AE 

PROVIDER: S-EPMC4380608 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature